Kenvue Inc. (KVUE) was delisted from the New York Stock Exchange on October 30, 2026, completing its acquisition by Kimberly-Clark Corp. (KMB). The deal is valued at approximately $40 billion and was first announced in late 2025.
The merger brings together Kenvue brands including Tylenol and Listerine with Kimberly-Clark brands including Huggies and Kleenex. The combined company is projected to generate annual revenue of around $32 billion, creating a global leader in consumer health and wellness.
The deal closed after receiving all necessary regulatory approvals. The final approvals came from authorities in China, Brazil and the European Union.